光毒性
皮肤病科
医学
晒伤
紫外线a
光敏性
多形性红斑
紫外线疗法
药品
红斑
银屑病
药理学
物理
化学
体外
量子力学
生物化学
作者
Luca Di Bartolomeo,Natasha Irrera,Giuseppe M. Campo,Francesco Borgia,Alfonso Motolese,Federico Vaccaro,Francesco Squadrito,Domenica Altavilla,Alessandra Grazia Condorelli,Alberico Motolese,Mario Vaccaro
标识
DOI:10.3389/falgy.2022.876695
摘要
Drug-induced photosensitivity (DIP) is a common cutaneous adverse drug reaction, resulting from the interaction of ultraviolet radiations, mostly ultraviolet A, with drugs. DIP includes phototoxicity and photoallergy. A phototoxic reaction is obtained when topical and systemic drugs or their metabolites absorb light inducing a direct cellular damage, while a photoallergic reaction takes place when the interaction between drugs and ultraviolet radiations causes an immune cutaneous response. Clinically, phototoxicity is immediate and appears as an exaggerated sunburn, whereas photoallergy is a delayed eczematous reaction. DIP may show several clinical subtypes. In this mini-review we report the pathogenetic mechanisms and causative drugs of DIP. We offer a detailed description of DIP clinical features in its classical and unusual subtypes, such as hyperpigmentation/dyschromia, pseudoporphyria, photo-onycolysis, eruptive teleangiectasia, pellagra-like reaction, lichenoid reaction, photodistributed erythema multiforme and subacute/chronic cutaneous lupus erythematosus. We described how physicians may early recognize and manage DIP, including diagnostic tests to rule out similar conditions. We made suggestions on how to improve sun exposure behaviors of patients at risk of DIP by means of an aware use of sunscreens, protective clothing and recent technologic tools. We highlighted the lack of sun safety programs addressed to patients at risk of DIP, who need a formal education about their condition.
科研通智能强力驱动
Strongly Powered by AbleSci AI